Detalhe da pesquisa
1.
Recombinant Deoxyribonuclease I Eye Drops for Ocular Graft Versus Host Disease: Results of a Randomized Clinical Trial.
Eye Contact Lens
; 50(5): 233-240, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38407974
2.
Novel Management of Ocular Surface Inflammation in Patients With Ocular Graft-Versus-Host Disease in the Setting of Cataract Surgery.
Eye Contact Lens
; 50(4): 189-193, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38350098
3.
"Window of Opportunity" in Ocular Graft-Versus-Host Disease Treatment: Results of a Longitudinal Study and Case Reports.
Eye Contact Lens
; 50(5): 222-232, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38477832
4.
Combinatorial therapy with immunosuppressive, immunomodulatory and tear substitute eyedrops ("Triple Play") in Recalcitrant Immunological Ocular Surface Diseases.
Ocul Surf
; 23: 1-11, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34768002
5.
Entry receptor bias in evolutionarily distant HSV-1 clinical strains drives divergent ocular and nervous system pathologies.
Ocul Surf
; 21: 238-249, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33766740
6.
Pathological consequences of anti-citrullinated protein antibodies in tear fluid and therapeutic potential of pooled human immune globulin-eye drops in dry eye disease.
Ocul Surf
; 18(1): 80-97, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31606460
7.
Neutrophil extracellular traps (NETs) contribute to pathological changes of ocular graft-vs.-host disease (oGVHD) dry eye: Implications for novel biomarkers and therapeutic strategies.
Ocul Surf
; 17(3): 589-614, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30965123
8.
A Phase I/II Placebo-Controlled Randomized Pilot Clinical Trial of Recombinant Deoxyribonuclease (DNase) Eye Drops Use in Patients With Dry Eye Disease.
Transl Vis Sci Technol
; 8(3): 10, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31110911